Syntara (ASX:SNT) Other Operating Expense : A$10.23 Mil (TTM As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Syntara Other Operating Expense?

Syntara's Other Operating Expense for the six months ended in Dec. 2023 was A$3.52 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$10.23 Mil.

Syntara's quarterly Other Operating Expense increased from Dec. 2022 (A$5.82 Mil) to Jun. 2023 (A$6.70 Mil) but then declined from Jun. 2023 (A$6.70 Mil) to Dec. 2023 (A$3.52 Mil).

Syntara's annual Other Operating Expense increased from Jun. 2021 (A$10.98 Mil) to Jun. 2022 (A$15.36 Mil) but then declined from Jun. 2022 (A$15.36 Mil) to Jun. 2023 (A$12.52 Mil).

Syntara Other Operating Expense Historical Data

The historical data trend for Syntara's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syntara Other Operating Expense Chart

Syntara Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Operating Expense

Get a 7-Day Free Trial

14.93

12.68

10.98

15.36

12.52

Syntara Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															6.28	9.08	5.82	6.70	3.52

Syntara Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$10.23 Mil.

Syntara Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Syntara's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Syntara (ASX:SNT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syntara Ltd (ASX:SNT) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

UUDA:Germany

Address

20 Rodborough Road, Locked Bag 5015, Frenchs Forest, Sydney, NSW, AUS, 2086

Website

https://www.pharmaxis.com.au

Syntara Ltd Formerly Pharmaxis Ltd is an Australia based pharmaceutical research company engaged in the research, development, and commercialization of human healthcare products for the treatment and management of fibrotic and inflammatory diseases. The firm's research efforts are focused on discovering drugs to treat inflammatory and fibrotic diseases such as NASH, pulmonary fibrosis, kidney and liver fibrosis and cancer from its amine oxidase inhibitor chemistry platform. Its product pipeline also includes Orbital and ASM8. The operating segments are Mannitol respiratory business and New Drug Development. It generates maximum revenue from Mannitol respiratory business segment.